Silence Therapeutics receives $2 million research payment | 26 February 2021
Silence Therapeutics receives $2 million research payment
Source: stockmarketwire.com
Page 6 - Mark Rothera News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mark Rothera. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mark Rothera Today - Breaking & Trending Today
Investegate | Company News | Corporate, London Stock Exchange, Regulatory News Headlines Silence Therapeutics raises $45m to fund drug pipeline
Investegate, Silence Therapeutics raises $45m to fund drug pipeline by BFN News From InvestEgate
Source: investegate.co.uk
Top UK Stocks to Watch: Beazley shares jump despite pandemic-induced loss
Beazley expects to bounce back strongly this year, Syncona’s investment in Achilles could benefit as it considers an IPO, Silence Therapeutics raises funds to help capitalise on current momentum, and energy suppliers like SSE and Centrica rise as Ofgem raises its price cap.
Source: cityindex.co.uk
Investegate | Company News | Corporate, London Stock Exchange, Regulatory News Headlines Silence Therapeutics appoints Craig Tooman as CFO
By BFN News | 09:23 AM | Wednesday 06 January, 2021 Silence Therapeutics, a biotechnology company that develops gene therapeutic technology based on RNA interference, has announced Craig Tooman as its new chief financial officer and Michael Davidson as a non-executive director of the board. Tooman has also become a member of the executive leadership team, effective immediately. His career in the biopharmaceutical industry spans more than 30 years, including 15 years of experience as a public company CFO. Most recently, he was CFO and chief operating officer at Vyome Therapeutics, and prior...
Source: investegate.co.uk